Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
Invasive and non-invasive neuromodulation in movement disorders
Invasive neuromodulation therapies in movement disorders that target specific brain regions have paved the way for modulation of specific underlying networks. Deep Brain Stimulation (DBS) is a well-established therapy for movement disorders - namely Parkinson disease, tremor, and dystonia - whereas non-invasive stimulation such as focused ultrasound stimulation (FUS), transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (TDCS) are in experimental or preclinical stages.
There is consensus that movement disorders are caused by dysfunction of neuronal circuits, which makes this a key target for patient treatment. At present, treating these disorders is primarily focused on phenotypes specific to Parkinson’s disease (i.e. motor symptoms, for example: dyskinesia, akinesia, tremor etc). However, non-motor symptoms also jeopardize the quality of life for individuals with these disorders, and should also be considered in treatment options. Treating the entire network dysfunction may therefore represent the best strategy to overcome both motor and non-motor symptoms.
This Collection will showcase developments in invasive and non-invasive neuromodulation therapies that will advance the field towards this aim for holistic treatment. We particularly welcome submissions on topics such as:
Developments in established invasive neuromodulation therapies (For ex: deep brain stimulation) for treating movement disorders patients specially Parkinson’s disease, tremor and dystonia.
Experimental and preclinical non-invasive stimulation therapies (FUS, TMS, TDCS, TACS) for treating movement disorders patients specially Parkinson’s disease, tremor, and dystonia.
Emerging neuromodulation (e.g. opto- or pharmaco- genetics, ultrasonic and neurofeedback) technologies and future perspective for treating movement disorders.
Electrophysiological approaches that foster and improve neuromodulation therapies.
Advanced multimodal neuroimaging techniques to derive underlying neuronal networks involved in movement disorders.
Translational approaches for improving invasive neuromodulation therapies for movement disorders.